StemRIM (TSE:4599) Total Operating Expense: 円1,493.12 Mil (TTM As of Jan. 2026)


TSE:4599 StemRIM Inc TSE:4599
31 GF Score
Price 円316.00
! 2 Warning Signs
View Full Analysis

What is StemRIM Total Operating Expense?

StemRIM TSE:4599 +1.94% 31 Total Operating Expense is 円1,493.12 Mil as of Jan. 2026. GuruFocus rates TSE:4599 with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

StemRIM's Total Operating Expense for the three months ended in Jan. 2026 was 円0.00 Mil. StemRIM's Total Operating Expense for the trailing twelve months (TTM) ended in Jan. 2026 was 円1,493.12 Mil.

StemRIM Total Operating Expense Related Terms

StemRIM Total Operating Expense Historical Data

* Premium members only.

The historical data trend for StemRIM's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

StemRIM Total Operating Expense Chart

StemRIM Annual Data
Trend Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only 1,993.73 2,003.66 2,207.61 2,076.08 1,971.53

StemRIM Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 445.69 459.76 541.96 0.00 491.40
TSE:4599
31GF Score
StemRIM Inc TSE:4599
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

StemRIM Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,493.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of 円1,493.12 Mil mean?
StemRIM (TSE:4599) has a Total Operating Expense of 円1,493.12 Mil as of Jan. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on StemRIM and its competitors.
Is StemRIM's Total Operating Expense too high?
StemRIM's current Total Operating Expense is 円1,493.12 Mil. Overall, StemRIM has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does StemRIM's Total Operating Expense compare to VRTX and REGN?
StemRIM's Total Operating Expense of 円1,493.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on StemRIM and its competitors. StemRIM's current Total Operating Expense is 円1,493.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is StemRIM stock overvalued right now?
StemRIM (TSE:4599) has a current Total Operating Expense of 円1,493.12 Mil. The current Total Operating Expense is 円1,493.12 Mil. StemRIM's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For StemRIM (TSE:4599), the current Total Operating Expense is 円1,493.12 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

StemRIM Business Description

Address 7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.
31GF Score

Get the complete analysis for TSE:4599

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円316.00
Price